MetLife Inc 5.625% Series E Preferred Stock
MET.PRE
4 hedge funds and large institutions have $8.44M invested in MetLife Inc 5.625% Series E Preferred Stock in 2024 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 2 reducing their positions, and 0 closing their positions.
33% more funds holding
Funds holding: 3 → 4 (+1)
13% more capital invested
Capital invested by funds: $7.44M → $8.44M (+$998K)
0.11% more ownership
Funds ownership: 0.95% → 1.06% (+0.11%)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WPP
Whalerock Point Partners
Providence,
Rhode Island
|
+$988K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CGH
Crossmark Global Holdings
Houston,
Texas
|
-$85.1K |
| 2 |
PNC Financial Services Group
Pittsburgh,
Pennsylvania
|
-$445 |
MET.PRE Hedge Fund Activity: Q3 2024 in Review
4 of the 6,965 institutional investors tracked by Wall St. Rank reported a position in MetLife Inc 5.625% Series E Preferred Stock (MET.PRE) for Q3 2024, worth a combined $8.44M — up 13% from $7.44M a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new MET.PRE positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 2 trimmed.
The largest buyer was Whalerock Point Partners, opening a new position worth an estimated $988K. The largest seller was Crossmark Global Holdings, cutting an estimated $85.1K.
- 4 institutional investors held MetLife Inc 5.625% Series E Preferred Stock (MET.PRE) as of Q3 2024, up from 3 in Q2 2024.
- Funds reported $8.44M of MetLife Inc 5.625% Series E Preferred Stock stock for Q3 2024, up 13% quarter-over-quarter.
- 1 fund opened new MetLife Inc 5.625% Series E Preferred Stock positions in Q3 2024 and 0 closed out, a net change of +1 holder.
- The largest MetLife Inc 5.625% Series E Preferred Stock buyer in Q3 2024 was Whalerock Point Partners, an estimated $988K added.
- The largest MetLife Inc 5.625% Series E Preferred Stock seller in Q3 2024 was Crossmark Global Holdings, an estimated $85.1K sold.
Based on aggregated 13F filings for Q3 2024.